申请人:Oxford Alexander William
公开号:US20080206163A1
公开(公告)日:2008-08-28
Compounds of general formula (I) wherein each of R
1
and R
2
independently represents a C
1-6
alkyl or C
2-7
acyl group; R
5
represents a hydrogen atom or a C
1-3
alkyl, C
2-3
alkenyl or C
2-3
alkynyl group; R
6
represents a hydrogen atom or a C
1-6
alkyl, C
2-6
alkenyl, C
2-6
alkynyl, amino, C
1-6
alkylamino, di(C
1-6
) alkylamino or C
2-7
acylamino group; each of R
7
and R
8
independently represents a hydrogen or halogen atom or a hydroxy, trifluoromethyl, C
1-6
alkyl, C
2-6
alkenyl, C
2-6
alkynyl, C
2-7
acyl, C
1-6
alkythio, C
1-6
alkoxy, C
3-6
cycloalkyl; and R
9
represents a hydrogen or halogen atom or a hydroxy, trifluoromethyl, C
1-6
alkyl, C
2-6
alkenyl, C
2-6
alkynyl, C
2-7
acyl, C
1-6
alkythio, C
1-6
alkoxy or C
3-6
cycloalkyl group; X represents OCH
2
or a group CR
3
R
4
, wherein each of R
3
and R
4
independently represents a hydrogen atom or a C
1-3
alkyl group; each of R
10
and R
11
independently represents a hydrogen atom, a C
1-3
alkyl, C
3-6
cycloalkyl or phenyl group; y represents an oxygen atom or a group CHNO
2
, NCN, NH or NNO
2
, n is an integer from 2 to 4; or a salt thereof; are useful for treatment of respiratory disorders such as asthma. Compounds of the invention have a longer duration of action than the known compound trequinsin (9,10-dimethoxy-3-methyl-2-mesitylimino-2,3,6,7-tetrahydro-4H-pyrimido[6,1-a]isoquinolin-4-one) and do not have trequinsin's very bitter taste.
通式(I)的化合物,其中R1和R2各自独立地表示C1-6烷基或C2-7酰基基团;R5表示氢原子或C1-3烷基,C2-3烯基或C2-3炔基基团;R6表示氢原子或C1-6烷基,C2-6烯基,C2-6炔基,氨基,C1-6烷基氨基,二(C1-6)烷基氨基或C2-7酰胺基团;R7和R8各自独立地表示氢或卤原子,或羟基,三氟甲基,C1-6烷基,C2-6烯基,C2-6炔基,C2-7酰基,C1-6烷硫基,C1-6烷氧基,C3-6环烷基;R9表示氢或卤原子,或羟基,三氟甲基,C1-6烷基,C2-6烯基,C2-6炔基,C2-7酰基,C1-6烷硫基,C1-6烷氧基或C3-6环烷基;X表示OCH2或CR3R4基团,其中R3和R4各自独立地表示氢原子或C1-3烷基;R10和R11各自独立地表示氢原子,C1-3烷基,C3-6环烷基或苯基;y表示氧原子或CHNO2,NCN,NH或NNO2基团,n为2到4的整数;或其盐;可用于治疗哮喘等呼吸系统疾病。本发明的化合物比已知化合物特雷昆辛(9,10-二甲氧基-3-甲基-2-间苯基亚胺-2,3,6,7-四氢-4H-嘧啶[6,1-a]异喹啉-4-酮)具有更长的作用时间,并且不具有特雷昆辛的非常苦涩的味道。